Effect of Mitofusin 2 on smooth muscle cells proliferation in hypoxic pulmonary hypertension

Microvascular Research

Volumn 84, Issue 3, 2012, Pages 286-296

  Zhang, Dandan ^a   Ma, Cui ^a   Li, Shanshan ^a,b   Ran, Yajuan ^a   Chen, Jianguo ^a   Lu, Ping ^a   Shi, Shuai ^a   Zhu, Daling ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Bio pharmaceutical Key Laboratory of Heilongjiang Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CYCLIN A; CYCLINE; MESSENGER RNA; MITOFUSIN 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTERIAL WALL THICKENING; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL FATE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA DETERMINATION; DOWN REGULATION; ENZYME ACTIVITY; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; HYPOXIA; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MORPHOMETRICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY ARTERY; PULMONARY ARTERY SMOOTH MUSCLE CELL; PULMONARY HYPERTENSION; RAT; REGULATORY MECHANISM; RNA INTERFERENCE; SMOOTH MUSCLE FIBER; UPREGULATION;

ANIMALS; ANOXIA; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CYCLIN A; DNA; HYPERTENSION, PULMONARY; LUNG; MALE; MEMBRANE PROTEINS; MITOCHONDRIAL PROTEINS; MYOCYTES, SMOOTH MUSCLE; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, WISTAR; RNA, SMALL INTERFERING; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84868089977     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2012.06.010     Document Type: Article

References (40)

1. Ahmadi-Simab K., et al. Treatment of pulmonary arterial hypertension (PAH) with oral endothelin-receptor antagonist bosentan in systemic sclerosis: BREATHE-1 trial and clinical experience. Z. Rheumatol. 2004, 63:495-497.
2. Archer S.L., et al. Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target. Circulation 2010, 121:2661-2671.
3. Benard G., Karbowski M. Mitochondrial fusion and division: regulation and role in cell viability. Semin. Cell Dev. Biol. 2009, 20:365-374.
4. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature 1993, 361:315-325.
5. Cartoni R., et al. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J. Physiol. 2005, 567:349-358.
6. Chan T.O., et al. Akt/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu. Rev. Biochem. 1999, 68:965-1014.
7. Chen H., et al. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J. Cell Biol. 2003, 160:189-200.
8. Chen K.H., et al. Dysregulation of HSG triggers vascular proliferative disorders. Nat. Cell Biol. 2004, 6:872-883.
9. Chen H., et al. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 2010, 141:280-289.
10. Chiche J., et al. Hypoxic enlarged mitochondria protect cancer cells from apoptotic stimuli. J. Cell. Physiol. 2010, 222:648-657.
11. Chiou W.F., et al. 3,4-Di-O-caffeoylquinic acid inhibits angiotensin-II-induced vascular smooth muscle cell proliferation and migration by downregulating the JNK and PI3K/Akt signaling pathways. Evid. Based Complement. Altern. Med. 2011, 2011:634502.
12. Dromparis P., et al. The role of mitochondria in pulmonary vascular remodeling. J. Mol. Med. (Berl.) 2010, 88:1003-1010.
13. Guo L., et al. Subacute hypoxia suppresses Kv3.4 channel expression and whole-cell K+ currents through endogenous 15-hydroxyeicosatetraenoic acid in pulmonary arterial smooth muscle cells. Eur. J. Pharmacol. 2008, 587:187-195.
14. Hirai K., et al. PI3K inhibition in neonatal rat brain slices during and after hypoxia reduces phospho-Akt and increases cytosolic cytochrome c and apoptosis. Brain Res. Mol. Brain Res. 2004, 124:51-61.
15. Howell K., et al. Chronic hypoxia causes angiogenesis in addition to remodelling in the adult rat pulmonary circulation. J. Physiol. 2003, 547:133-145.
16. Jeffery T.K., Wanstall J.C. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol. Ther. 2001, 92:1-20.
17. Kane L.A., Youle R.J. Mitochondrial fission and fusion and their roles in the heart. J Mol Med (Berl) 2010, 88:971-979.
18. Lee J.H., Ragolia L. Akt phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 2006, 291:C1355-C1365.
19. Li Q., Zhu G.D. Targeting serine/threonine protein kinase B/Akt and cell-cycle checkpoint kinases for treating cancer. Curr. Top. Med. Chem. 2002, 2:939-971.
20. Li Y., et al. ANG II induces apoptosis of human vascular smooth muscle via extrinsic pathway involving inhibition of Akt phosphorylation and increased FasL expression. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H2116-H2123.
21. Li Y., et al. 15-HETE suppresses K(+) channel activity and inhibits apoptosis in pulmonary artery smooth muscle cells. Apoptosis 2009, 14:42-51.
22. Li Y., et al. Peroxisome proliferator-activated receptor delta regulates mitofusin 2 expression in the heart. J. Mol. Cell. Cardiol. 2009, 46:876-882.
23. Ma J., et al. ROCK pathway participates in the processes that 15-hydroxyeicosatetraenoic acid (15-HETE) mediated the pulmonary vascular remodeling induced by hypoxia in rat. J. Cell. Physiol. 2010, 222:82-94.
24. Mandegar M., et al. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. Microvasc. Res. 2004, 68:75-103.
25. Mattson M.P., Kroemer G. Mitochondria in cell death: novel targets for neuroprotection and cardioprotection. Trends Mol. Med. 2003, 9:196-205.
26. Misko A., et al. Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J. Neurosci. 2010, 30:4232-4240.
27. Pawlikowska P., et al. Mitofusin 2 (Mfn2): a key player in insulin-dependent myogenesis in vitro. Cell Tissue Res. 2007, 327:571-581.
28. Pidgeon G.P., et al. Intravascular thrombosis after hypoxia-induced pulmonary hypertension: regulation by cyclooxygenase-2. Circulation 2004, 110:2701-2707.
29. Preston I.R., et al. Role of 12-lipoxygenase in hypoxia-induced rat pulmonary artery smooth muscle cell proliferation. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 290:L367-L374.
30. Rojo M., et al. Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo. J. Cell Sci. 2002, 115:1663-1674.
31. Sahara M., et al. Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation. Circulation 2007, 115:509-517.
32. Srinivasan R., et al. Hypopyon iritis after primary fresh amniotic membrane transplantation. Cornea 2007, 26:1275-1276.
33. Stenmark K.R., et al. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ. Res. 2006, 99:675-691.
34. Sutendra G., et al. The role of Nogo and the mitochondria-endoplasmic reticulum unit in pulmonary hypertension. Sci. Transl. Med. 2011, 3:88ra55.
35. Wang S., et al. 15-HETE protects rat pulmonary arterial smooth muscle cells from apoptosis via the PI3K/Akt pathway. Prostaglandins Other Lipid Mediat. 2010, 91:51-60.
36. Yang X., et al. Hypoxic induction of cox-2 regulates proliferation of human pulmonary artery smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 2002, 27:688-696.
37. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9:47-59.
38. Zaiman A., et al. One hundred years of research in the pathogenesis of pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 2005, 33:425-431.
39. Zheng X., et al. Source of the elevation Ca2+ evoked by 15-HETE in pulmonary arterial myocytes. Eur. J. Pharmacol. 2008, 601:16-22.
40. Zhu D., et al. Chronic hypoxia activates lung 15-lipoxygenase, which catalyzes production of 15-HETE and enhances constriction in neonatal rabbit pulmonary arteries. Circ. Res. 2003, 92:992-1000.